Sickle cell disease (SCD) is among the most common genetic diseases, with a recent increase in life expectancy. Patients may therefore need similar surgical procedures as does the general population, including cardiac surgery. Cardiopulmonary bypass is a homeostasis challenge for SCD patients, with high risk of vasoocclusive crisis. In the most severe cases of cardiogenic shock, venoarterial extracorporeal membrane oxygenation (VA-ECMO) may be required, with prolonged exposure to extreme nonphysiological conditions. We report a case of postcardiotomy shock in an SCD patient successfully managed with VA-ECMO. This highlights that SCD should not be a counterindication to VA-ECMO, pending multidisciplinary management.

Venoarterial Extracorporeal Membrane Oxygenation in Sickle Cell Disease for Urgent Cardiac Surgery / de Roux, Q.; Maghrebi, S.; Fiore, A.; Arminot-Fremaux, M.; Dessalle, T.; Lim, P.; Folliguet, T.; Bartolucci, P.; Langeron, O.; Mongardon, N.. - In: ANNALS OF THORACIC SURGERY. - ISSN 0003-4975. - 109:3(2020), pp. e161-e162. [10.1016/j.athoracsur.2019.05.093]

Venoarterial Extracorporeal Membrane Oxygenation in Sickle Cell Disease for Urgent Cardiac Surgery

Fiore A.;
2020

Abstract

Sickle cell disease (SCD) is among the most common genetic diseases, with a recent increase in life expectancy. Patients may therefore need similar surgical procedures as does the general population, including cardiac surgery. Cardiopulmonary bypass is a homeostasis challenge for SCD patients, with high risk of vasoocclusive crisis. In the most severe cases of cardiogenic shock, venoarterial extracorporeal membrane oxygenation (VA-ECMO) may be required, with prolonged exposure to extreme nonphysiological conditions. We report a case of postcardiotomy shock in an SCD patient successfully managed with VA-ECMO. This highlights that SCD should not be a counterindication to VA-ECMO, pending multidisciplinary management.
2020
n/a
01 Pubblicazione su rivista::01a Articolo in rivista
Venoarterial Extracorporeal Membrane Oxygenation in Sickle Cell Disease for Urgent Cardiac Surgery / de Roux, Q.; Maghrebi, S.; Fiore, A.; Arminot-Fremaux, M.; Dessalle, T.; Lim, P.; Folliguet, T.; Bartolucci, P.; Langeron, O.; Mongardon, N.. - In: ANNALS OF THORACIC SURGERY. - ISSN 0003-4975. - 109:3(2020), pp. e161-e162. [10.1016/j.athoracsur.2019.05.093]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1618286
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact